Progesterone vaginal - Besins Healthcare

Drug Profile

Progesterone vaginal - Besins Healthcare

Alternative Names: Utrogestan

Latest Information Update: 23 May 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Besins Healthcare
  • Class Hormonal contraceptives; Hormonal replacements; Infertility therapies; Pregnenediones; Small molecules
  • Mechanism of Action Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Amenorrhoea; Breast disorders; Breast pain; Endometriosis; Female infertility; Menopausal syndrome; Menstruation disorders; Premenstrual syndrome; Preterm labour; Spontaneous abortion

Most Recent Events

  • 08 May 2017 The Scottish Medicines Consortium approves progesterone vaginal in women for supplementation of the luteal phase during Assisted Reproductive Technology (ART) cycles
  • 24 Aug 2015 Ewha Womans University and Han Wha Pharma plan a phase III trial for Preterm labour (Prevention) in South Korea (NCT02304237)
  • 22 Jul 2013 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top